Yinghui Zhou

Executive Director @Synnovation Therapeutics

Cambridge, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

May 2024 — Present

Executive Director @Synnovation Therapeutics

View department →

Wilmington, DE, US

EDUCATION

1994 — 2000

Northwestern University

Ph.D, Biochemistry, Molecular Biology and Cell Biology

1989 — 1993

Nankai University

B.S, Ecology and Environmental biology

SKILLS

GenomicsGeneticsMicroarrayAssay DevelopmentAntibodiesClinical DevelopmentMolecular BiologyCell BiologyBiotechnologyDnaAnimal ModelsCellTranslational ResearchIn VitroDrug DevelopmentCancerDrug DiscoveryPcrIn VivoPharmacology

ABOUT YINGHUI ZHOU

Accomplished leader in oncology translational science with extensive experience spanning discovery research, early clinical development, and registration trials; contributed to four FDA approved therapies (Zejula, Jemperli, Elahere, Fotivda); In depth knowledge of wide range of therapeutic modalities including small molecule, biologics, ADC, and radionuclide therapies; Comprehensive technical expertise in pharmacology, biomarker discovery, assay development and validation; Co-led development of an FDA approved CDx (FOLR1-2.1); Key contributor to several highly successful industry and academic collaborations; Skilled in mentoring junior scientists and building collaborative, productive teams. Consistently delivered high quality results against aggressive timelines

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Yinghui Zhou — Executive Director at Synnovation Therapeutics in Cambridge, MA, US | Unifers